James E Flynn Insider Trading Transactions
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Latest Insider Trading Transactions of James E Flynn
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: < prev 1 ... 5 6 7 8 9 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.25 | 96,075 | 23,961 | 937,342 | 1 M to 937.3 K (-9.30 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.26 | 1,001,720 | 257,342 | 1,033,417 | 2 M to 1 M (-49.22 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.25 | 125,000 | 30,625 | 0 | 125 K to 0 (-100.00 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.24 | 329,437 | 79,559 | 125,000 | 454.4 K to 125 K (-72.49 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.23 | 129,981 | 29,402 | 454,437 | 584.4 K to 454.4 K (-22.24 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.24 | 183,000 | 43,792 | 584,418 | 767.4 K to 584.4 K (-23.85 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.23 | 23,740 | 5,391 | 767,418 | 791.2 K to 767.4 K (-3.00 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.28 | 54,900 | 15,345 | 791,158 | 846.1 K to 791.2 K (-6.49 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.25 | 36,600 | 9,150 | 846,058 | 882.7 K to 846.1 K (-4.15 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.25 | 55,463 | 13,832 | 882,658 | 938.1 K to 882.7 K (-5.91 %) |
Oct 24 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Sell | S | 0.26 | 578,280 | 148,560 | 938,121 | 1.5 M to 938.1 K (-38.14 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.24 | 131,836 | 31,641 | 881,743 | 1 M to 881.7 K (-13.01 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.24 | 56,957 | 13,670 | 503,348 | 560.3 K to 503.3 K (-10.17 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.26 | 128,800 | 33,488 | 1,013,579 | 1.1 M to 1 M (-11.27 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.26 | 71,200 | 18,512 | 560,305 | 631.5 K to 560.3 K (-11.27 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.44 | 34,431 | 15,150 | 1,142,379 | 1.2 M to 1.1 M (-2.93 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.44 | 19,033 | 8,375 | 631,505 | 650.5 K to 631.5 K (-2.93 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.56 | 644 | 361 | 1,176,810 | 1.2 M to 1.2 M (-0.05 %) |
Nov 20 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.56 | 356 | 199 | 650,538 | 650.9 K to 650.5 K (-0.05 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.49 | 23,378 | 11,455 | 1,177,454 | 1.2 M to 1.2 M (-1.95 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.49 | 12,922 | 6,332 | 650,894 | 663.8 K to 650.9 K (-1.95 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.48 | 85,865 | 41,215 | 1,200,832 | 1.3 M to 1.2 M (-6.67 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.48 | 47,465 | 22,783 | 663,816 | 711.3 K to 663.8 K (-6.67 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.50 | 82,819 | 41,410 | 1,286,697 | 1.4 M to 1.3 M (-6.05 %) |
Nov 14 2008 | CYCC | Cyclacel Pharmaceu ... | Flynn James E | 10% Owner | Sell | S | 0.50 | 45,781 | 22,891 | 711,281 | 757.1 K to 711.3 K (-6.05 %) |
Aug 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 1,317 | 1,330 | 3,580,090 | 3.6 M to 3.6 M (+0.04 %) |
Aug 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 718 | 725 | 1,945,255 | 1.9 M to 1.9 M (+0.04 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 6,762 | 6,830 | 3,578,773 | 3.6 M to 3.6 M (+0.19 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 3,688 | 3,725 | 1,944,537 | 1.9 M to 1.9 M (+0.19 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 7,118 | 7,189 | 3,572,011 | 3.6 M to 3.6 M (+0.20 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 3,882 | 3,921 | 1,940,849 | 1.9 M to 1.9 M (+0.20 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 635 | 641 | 3,564,893 | 3.6 M to 3.6 M (+0.02 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 345 | 348 | 1,936,967 | 1.9 M to 1.9 M (+0.02 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 32,441 | 32,441 | 3,564,258 | 3.5 M to 3.6 M (+0.92 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 17,699 | 17,699 | 1,936,622 | 1.9 M to 1.9 M (+0.92 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 5,791 | 5,936 | 3,531,817 | 3.5 M to 3.5 M (+0.16 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 3,159 | 3,238 | 1,918,923 | 1.9 M to 1.9 M (+0.16 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 12,876 | 12,876 | 3,526,026 | 3.5 M to 3.5 M (+0.37 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 7,024 | 7,024 | 1,915,764 | 1.9 M to 1.9 M (+0.37 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 7,733 | 7,888 | 3,513,150 | 3.5 M to 3.5 M (+0.22 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 4,219 | 4,303 | 1,908,740 | 1.9 M to 1.9 M (+0.22 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 38,249 | 38,631 | 3,505,417 | 3.5 M to 3.5 M (+1.10 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 20,868 | 21,077 | 1,904,521 | 1.9 M to 1.9 M (+1.11 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 28,222 | 28,786 | 3,467,168 | 3.4 M to 3.5 M (+0.82 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 15,397 | 15,705 | 1,883,653 | 1.9 M to 1.9 M (+0.82 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.99 | 770 | 762 | 3,438,946 | 3.4 M to 3.4 M (+0.02 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.99 | 420 | 416 | 1,868,256 | 1.9 M to 1.9 M (+0.02 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 272 | 275 | 3,438,176 | 3.4 M to 3.4 M (+0.01 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 148 | 149 | 1,867,836 | 1.9 M to 1.9 M (+0.01 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 16,137 | 16,460 | 3,437,904 | 3.4 M to 3.4 M (+0.47 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 8,803 | 8,979 | 1,867,688 | 1.9 M to 1.9 M (+0.47 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.97 | 15,650 | 15,181 | 3,421,767 | 3.4 M to 3.4 M (+0.46 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.97 | 8,538 | 8,282 | 1,858,885 | 1.9 M to 1.9 M (+0.46 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 12,380 | 12,132 | 3,406,117 | 3.4 M to 3.4 M (+0.36 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 6,754 | 6,619 | 1,850,347 | 1.8 M to 1.9 M (+0.37 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.95 | 22,061 | 20,958 | 3,393,737 | 3.4 M to 3.4 M (+0.65 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.95 | 12,035 | 11,433 | 1,843,593 | 1.8 M to 1.8 M (+0.66 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 5,805 | 5,799 | 3,371,676 | 3.4 M to 3.4 M (+0.17 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 3,165 | 3,162 | 1,831,558 | 1.8 M to 1.8 M (+0.17 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 23,629 | 23,156 | 3,365,871 | 3.3 M to 3.4 M (+0.71 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 12,891 | 12,633 | 1,828,393 | 1.8 M to 1.8 M (+0.71 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 195 | 197 | 3,342,242 | 3.3 M to 3.3 M (+0.01 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 105 | 106 | 1,815,502 | 1.8 M to 1.8 M (+0.01 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 25,581 | 25,069 | 3,342,047 | 3.3 M to 3.3 M (+0.77 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 13,894 | 13,616 | 1,815,397 | 1.8 M to 1.8 M (+0.77 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 27,148 | 27,962 | 3,316,466 | 3.3 M to 3.3 M (+0.83 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 14,747 | 15,189 | 1,801,503 | 1.8 M to 1.8 M (+0.83 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 2,151 | 2,216 | 3,289,318 | 3.3 M to 3.3 M (+0.07 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 1,167 | 1,202 | 1,786,756 | 1.8 M to 1.8 M (+0.07 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 11,783 | 13,550 | 3,287,167 | 3.3 M to 3.3 M (+0.36 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 6,399 | 7,359 | 1,785,589 | 1.8 M to 1.8 M (+0.36 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 43,079 | 49,541 | 3,275,384 | 3.2 M to 3.3 M (+1.33 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 23,400 | 26,910 | 1,779,190 | 1.8 M to 1.8 M (+1.33 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 14,827 | 17,051 | 3,232,305 | 3.2 M to 3.2 M (+0.46 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 8,053 | 9,261 | 1,755,790 | 1.7 M to 1.8 M (+0.46 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 34,350 | 38,472 | 3,180,899 | 3.1 M to 3.2 M (+1.09 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 18,659 | 20,898 | 1,727,870 | 1.7 M to 1.7 M (+1.09 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.17 | 17,043 | 19,940 | 3,146,549 | 3.1 M to 3.1 M (+0.54 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.17 | 9,257 | 10,831 | 1,709,211 | 1.7 M to 1.7 M (+0.54 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.21 | 29,258 | 35,402 | 3,129,506 | 3.1 M to 3.1 M (+0.94 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.21 | 15,891 | 19,228 | 1,699,954 | 1.7 M to 1.7 M (+0.94 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.16 | 16,383 | 19,004 | 3,217,478 | 3.2 M to 3.2 M (+0.51 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.16 | 8,899 | 10,323 | 1,747,737 | 1.7 M to 1.7 M (+0.51 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 8,878 | 9,943 | 3,201,095 | 3.2 M to 3.2 M (+0.28 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 4,821 | 5,400 | 1,738,838 | 1.7 M to 1.7 M (+0.28 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.14 | 11,318 | 12,903 | 3,192,217 | 3.2 M to 3.2 M (+0.36 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.14 | 6,147 | 7,008 | 1,734,017 | 1.7 M to 1.7 M (+0.36 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 48,929 | 61,651 | 3,100,248 | 3.1 M to 3.1 M (+1.60 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 26,578 | 33,488 | 1,684,063 | 1.7 M to 1.7 M (+1.60 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.27 | 45,338 | 57,579 | 3,051,319 | 3 M to 3.1 M (+1.51 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.27 | 24,626 | 31,275 | 1,657,485 | 1.6 M to 1.7 M (+1.51 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 10,757 | 13,554 | 3,005,981 | 3 M to 3 M (+0.36 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 5,843 | 7,362 | 1,632,859 | 1.6 M to 1.6 M (+0.36 %) |
Jun 30 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.65 | 105,300 | 594,945 | 105,300 | |
Jun 30 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.65 | 61,300 | 346,345 | 61,300 | |
Jun 30 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.65 | 519,200 | 2,933,480 | 519,200 | |
Jun 30 2008 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.65 | 314,200 | 1,775,230 | 314,200 | |
Nov 07 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.21 | 39,904 | 128,092 | 1,244,708 | 1.3 M to 1.2 M (-3.11 %) |
Nov 07 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.38 | 64 | 216 | 1,284,612 | 1.3 M to 1.3 M (0.00 %) |
Nov 07 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.21 | 23,234 | 74,581 | 724,779 | 748 K to 724.8 K (-3.11 %) |
Nov 07 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.38 | 36 | 122 | 748,013 | 748 K to 748 K (0.00 %) |
Nov 02 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.97 | 74 | 293 | 1,284,676 | 1.3 M to 1.3 M (-0.01 %) |
Nov 02 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.97 | 42 | 167 | 748,049 | 748.1 K to 748 K (-0.01 %) |
Oct 30 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.92 | 1,459 | 5,725 | 1,284,750 | 1.3 M to 1.3 M (-0.11 %) |
Oct 30 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.92 | 848 | 3,327 | 748,091 | 748.9 K to 748.1 K (-0.11 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.88 | 1,359 | 5,267 | 1,286,209 | 1.3 M to 1.3 M (-0.11 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.91 | 8,322 | 32,576 | 1,287,568 | 1.3 M to 1.3 M (-0.64 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.97 | 64 | 254 | 1,295,890 | 1.3 M to 1.3 M (0.00 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.98 | 445 | 1,771 | 1,295,954 | 1.3 M to 1.3 M (-0.03 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.88 | 790 | 3,062 | 748,939 | 749.7 K to 748.9 K (-0.11 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.91 | 4,845 | 18,966 | 749,729 | 754.6 K to 749.7 K (-0.64 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.97 | 36 | 143 | 754,574 | 754.6 K to 754.6 K (0.00 %) |
Oct 26 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.98 | 259 | 1,031 | 754,610 | 754.9 K to 754.6 K (-0.03 %) |
Oct 19 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.98 | 582 | 2,316 | 1,296,399 | 1.3 M to 1.3 M (-0.04 %) |
Oct 19 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 4.03 | 3,430 | 13,807 | 1,296,981 | 1.3 M to 1.3 M (-0.26 %) |
Oct 19 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 3.98 | 338 | 1,345 | 754,869 | 755.2 K to 754.9 K (-0.04 %) |
Oct 19 2007 | CAQ | VIA Pharmaceutical ... | Flynn James E | 10% Owner | Sell | S | 4.03 | 1,995 | 8,030 | 755,207 | 757.2 K to 755.2 K (-0.26 %) |
Nov 01 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.75 | 136,890 | 787,118 | 136,890 | |
Nov 01 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.75 | 79,960 | 459,770 | 79,960 | |
Nov 01 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.75 | 674,960 | 3,881,020 | 674,960 | |
Nov 01 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.75 | 408,460 | 2,348,645 | 408,460 | |
Oct 23 2007 | ARNA | ARENA PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 10.51 | 15,875 | 166,805 | 3,238,908 | 3.3 M to 3.2 M (-0.49 %) |
Oct 23 2007 | ARNA | ARENA PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 10.51 | 9,125 | 95,880 | 1,861,735 | 1.9 M to 1.9 M (-0.49 %) |
Jul 20 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.13 | 131,625 | 675,236 | 131,625 | |
Jul 20 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.13 | 76,625 | 393,086 | 76,625 | |
Jul 20 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.13 | 649,000 | 3,329,370 | 649,000 | |
Jul 20 2007 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Option Exercise | P | 5.13 | 392,750 | 2,014,808 | 392,750 | |
May 22 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.45 | 218,805 | 1,192,903 | 734,795 | 953.6 K to 734.8 K (-22.95 %) |
May 22 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.45 | 108,749 | 592,889 | 365,205 | 474 K to 365.2 K (-22.95 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.66 | 40,977 | 232,094 | 953,600 | 994.6 K to 953.6 K (-4.12 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.73 | 2,385 | 13,678 | 994,577 | 997 K to 994.6 K (-0.24 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.72 | 3,006 | 17,195 | 996,962 | 1000 K to 997 K (-0.30 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.66 | 20,364 | 115,342 | 473,954 | 494.3 K to 474 K (-4.12 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.73 | 1,185 | 6,796 | 494,318 | 495.5 K to 494.3 K (-0.24 %) |
Apr 27 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.72 | 1,494 | 8,546 | 495,503 | 497 K to 495.5 K (-0.30 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.75 | 18,513 | 106,466 | 999,968 | 1 M to 1000 K (-1.82 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.77 | 24,163 | 139,498 | 1,018,481 | 1 M to 1 M (-2.32 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.76 | 15,231 | 87,664 | 1,042,644 | 1.1 M to 1 M (-1.44 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.75 | 9,201 | 52,914 | 496,997 | 506.2 K to 497 K (-1.82 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.77 | 12,008 | 69,325 | 506,198 | 518.2 K to 506.2 K (-2.32 %) |
Apr 24 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.76 | 7,569 | 43,564 | 518,206 | 525.8 K to 518.2 K (-1.44 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.82 | 15,399 | 89,607 | 1,057,875 | 1.1 M to 1.1 M (-1.43 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.90 | 3,808 | 22,467 | 1,073,274 | 1.1 M to 1.1 M (-0.35 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.90 | 167,001 | 985,306 | 1,077,082 | 1.2 M to 1.1 M (-13.42 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.82 | 7,651 | 44,521 | 525,775 | 533.4 K to 525.8 K (-1.43 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.90 | 1,892 | 11,163 | 533,426 | 535.3 K to 533.4 K (-0.35 %) |
Apr 20 2007 | TWTI | THIRD WAVE TECHNOL ... | Flynn James E | 10% Owner | Sell | S | 5.90 | 82,999 | 489,694 | 535,318 | 618.3 K to 535.3 K (-13.42 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 177,129 | 1,369,792 | 2,307,449 | 2.5 M to 2.3 M (-7.13 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 134,645 | 1,041,250 | 1,754,062 | 1.9 M to 1.8 M (-7.13 %) |
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 59,879 | 463,068 | 781,151 | 841 K to 781.2 K (-7.12 %) |